Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-25 | Mr. Carey received his B.S. in accounting from the University of Notre Dame. Mr. Carey’s extensive experience in healthcare investment banking and business development. |
| 2017-04-25 | Mr. Carey has been executive vice president, chief business officer for Horizon Pharma plc, a biopharmaceutical company, since March 2014. Prior to that, he served as managing director and head of the healthcare investment banking group at JMP Securities LLC. |
| 2018-04-24 | Mr. Carey received his B.S. in accounting from the University of Notre Dame. |
| 2019-04-25 | Mr. Carey received his B.S. in accounting from the University of Notre Dame. |
| 2020-04-02 | Mr. Carey received his B.S. in accounting from the University of Notre Dame. |
| 2021-04-02 | Mr. Carey has served as co-founder, president and chief operating officer of ACELYRIN, Inc., a privately-held biopharmaceutical company, since July 2020. Mr. Carey has served as Executive Vice President, Chief Business Officer for Horizon Therapeutics plc, a biopharmaceutical company, from March 2014 to October 2019. |
| 2022-04-01 | Mr. Carey has served as co-founder and president of ACELYRIN, Inc., a privately-held biopharmaceutical company, since July 2020. Mr. Carey served as Executive Vice President, Chief Business Officer for Horizon Therapeutics plc, a biopharmaceutical company, from March 2014 to October 2019. Prior to that, he served as managing director and head of the healthcare investment banking group at JMP Securities LLC, a full-service investment bank from 2003 to 2014. |
| 2023-04-17 | Mr. Carey received his BBA in accountancy from the University of Notre Dame. |
| 2024-04-19 | Mr. Carey served as co-founder and president of ACELYRIN, Inc., a biopharmaceutical company, from July 2020 to December 2022. Prior to that, Mr. Carey served as Executive Vice President, Chief Business Officer for Horizon Therapeutics plc, a biopharmaceutical company, from March 2014 to October 2019. |
Data sourced from SEC filings. Last updated: 2025-10-12